Bridging Interventional Development Gaps program

E93887

The Bridging Interventional Development Gaps program is a National Center for Advancing Translational Sciences initiative that provides resources and expertise to help advance promising therapeutic candidates through critical preclinical and early clinical development stages.

AI illustration

How this image was made

AI-generated illustration of Bridging Interventional Development Gaps program

This AI-generated illustration was produced by black-forest-labs/FLUX.2-dev (1024x1024) from a prompt written by openai/gpt-oss-120b from the entity's label + description.

Prompt

Generate an image of the Bridging Interventional Development Gaps program (The Bridging Interventional Development Gaps program is a National Center for Advancing Translational Sciences initiative that provides resources and expertise to help advance promising therapeutic candidates through critical preclinical and early clinical development stages.)

All labels observed (1)

Label Occurrences
Bridging Interventional Development Gaps program canonical 1

How this entity was disambiguated

Statements (46)

Predicate Object
instanceOf NCATS program ⓘ
drug development support program ⓘ
therapeutic development initiative ⓘ
aimsTo advance promising therapeutic candidates ⓘ
collaboratesWith academic medical centers ⓘ
industry partners ⓘ
patient advocacy groups ⓘ
country United States ⓘ
emphasis first-in-human enabling studies ⓘ
rare and orphan diseases ⓘ
unmet medical needs ⓘ
field drug development ⓘ
translational science ⓘ
focusesOn critical preclinical development stages ⓘ
early clinical development stages ⓘ
fundingModel collaborative agreements ⓘ
in-kind support ⓘ
goal bridge gaps between basic research and clinical application ⓘ
de-risk therapeutic candidates for further development ⓘ
objective accelerate translation of discoveries into therapies ⓘ
reduce time and risk in early drug development ⓘ
offers clinical protocol development assistance ⓘ
formulation development ⓘ
manufacturing support ⓘ
pharmacokinetics studies ⓘ
regulatory strategy support ⓘ
toxicology studies ⓘ
operatedBy National Center for Advancing Translational Sciences ⓘ
parentOrganization National Institutes of Health ⓘ
partOf National Center for Advancing Translational Sciences ⓘ
provides drug development expertise ⓘ
resources for therapeutic development ⓘ
selectionProcess competitive application review ⓘ
sponsor early clinical development projects ⓘ
preclinical development projects ⓘ
supports biologics ⓘ
gene therapies ⓘ
small molecules ⓘ
therapeutics for neglected diseases ⓘ
therapeutics for rare diseases ⓘ
supportsStage IND-enabling studies ⓘ
Phase I clinical trials ⓘ
proof-of-concept clinical studies ⓘ
targetAudience academic investigators ⓘ
nonprofit research organizations ⓘ
small biotechnology companies ⓘ

How these facts were elicited

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

National Center for Advancing Translational Sciences → operates → Bridging Interventional Development Gaps program ⓘ